Lyra Therapeutics Inc (LYRA) support and resistance · rev $1.5M
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
This page maps Lyra Therapeutics Inc (LYRA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
LYRA currently screens at market cap $14.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LYRA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LYRA quote page for the session range and the stock page for the full model.
Not investment advice.